Capital World Investors

Holdings History for Allogene Therapeutics, Inc. - Common Stock (ALLO)

Symbol: ALLO on Nasdaq
Investment type: Equity / Common Stock
Latest Disclosed Shares Owned: 0 shares
Security Ownership %: 0%

Shares, Excluding Options vs Price

Value, Excluding Options

Capital World Investors ownership in Allogene Therapeutics, Inc. Common Stock (ALLO)

13 Nov 2025 - Capital World Investors has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 0 shares of Allogene Therapeutics, Inc. Common Stock (ALLO). This represents 0% ownership of the company. In their previous filing dated 13 May 2025, Capital World Investors had reported owning 12,265,330 shares, indicating a decrease of +100%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Capital World Investors	0%	-93%	$0	0	-12,265,330	-100%	$1.24	13G/A	30 Sep 2025	13 Nov 2025, 19:06
Capital World Investors	5.6%		$18,888,608	12,265,330			$1.54	13G	31 Mar 2025	13 May 2025, 11:44

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
30 Sep 2025		-0%	$0	0	-11,150,000	-100%	$1.62	Q3 2025
30 Jun 2025	0%	-0%	$12,599,500	11,150,000	-1,115,330	-9.1%	$1.13	Q2 2025
31 Mar 2025	0%	+0%	$17,907,382	12,265,330	+5,368,778		$1.46	Q1 2025
31 Dec 2024	0%	0%	$14,689,656	6,896,552	0		$2.13	Q4 2024
30 Sep 2024	0%	0%	$19,310,346	6,896,552	0		$2.80	Q3 2024
30 Jun 2024	0%	+0%	$16,068,966	6,896,552	+6,896,552	NEW	$2.33	Q2 2024
31 Mar 2022		-0%	$0	0	-1,300,000	-100%	$1.62	Q1 2022
31 Dec 2021	0%	-0%	$19,396,000	1,300,000	-946,576	-42%	$14.92	Q4 2021
30 Sep 2021	0.01%	0%	$57,737,000	2,246,576	-1	-0%	$25.70	Q3 2021
30 Jun 2021	0.01%	0%	$58,591,000	2,246,577	-26	-0%	$26.08	Q2 2021
31 Mar 2021	0.01%	-0%	$79,305,000	2,246,603	-125,214	-5.3%	$35.30	Q1 2021
31 Dec 2020	0.01%	-0%	$59,865,000	2,371,817	-293,869	-11%	$25.24	Q4 2020
30 Sep 2020	0.02%	-0.01%	$100,523,000	2,665,686	-815,438	-23%	$37.71	Q3 2020
30 Jun 2020	0.04%	+0.01%	$149,062,000	3,481,124	+503,460	+17%	$42.82	Q2 2020
31 Mar 2020	0.02%	0%	$57,886,000	2,977,664	0		$19.44	Q1 2020
31 Dec 2019	0.02%	-0%	$77,360,000	2,977,664	-298,021	-9.1%	$25.98	Q4 2019
30 Sep 2019	0.02%	+0%	$89,279,000	3,275,685	+501,104	+18%	$27.26	Q3 2019
30 Jun 2019	0.02%	+0%	$74,497,000	2,774,581	+603,098	+28%	$26.85	Q2 2019
31 Mar 2019	0.02%	0%	$62,778,000	2,171,483	0		$28.91	Q1 2019
31 Dec 2018	0.02%	+0.02%	$58,478,000	2,171,483	+2,171,483	NEW	$26.93	Q4 2018

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.